SEC INSIDER TRANSACTIONS

Medtronic plc (MDT) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

MDT · Medtronic plc

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-10-27 · 29 filings · fetched 2026-10-27T16:20:59Z

Recent reported activity

0purchase rows on this page

0sale rows on this page

59matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Ownership	Source
2026-05-26Filed 2026-05-28	Walter Matthew R.Officer · SVP, Chief HR Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026. F2 Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F3 The performance share units vested on April 24, 2026. References: F1	M Exercise / conversionOrdinary Shares · Non-derivative	9,149A	Direct	Form 4 ↗0002028475-26-000004
2026-05-26Filed 2026-05-28	Marinaro MichaelOfficer · EVP, Pres MedSurg and Americas Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026. F2 Includes 781 shares acquired through dividend reinvestment since the last report filed by the reporting person. F3 Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 The performance share units vested on April 24, 2026. References: F3, F4	M Exercise / conversionPerformance Share Unit · Derivative	17,093D	Direct	Form 4 ↗0001984186-26-000002
2026-05-26Filed 2026-05-28	Marinaro MichaelOfficer · EVP, Pres MedSurg and Americas Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026. F2 Includes 781 shares acquired through dividend reinvestment since the last report filed by the reporting person. F3 Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 The performance share units vested on April 24, 2026. References: F1, F2	M Exercise / conversionOrdinary Shares · Non-derivative	18,994A	Direct	Form 4 ↗0001984186-26-000002
2026-05-26Filed 2026-05-28	KIIL HARRY SKIPOfficer · EVP & President Cardiovascular Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026. F2 Includes 270 shares acquired through dividend reinvestment since the last report filed by the reporting person. F3 Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 The performance share units vested on April 24, 2026. References: F3, F4	M Exercise / conversionPerformance Share Unit · Derivative	14,517D	Direct	Form 4 ↗0001708062-26-000004
2026-05-26Filed 2026-05-28	KIIL HARRY SKIPOfficer · EVP & President Cardiovascular Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026. F2 Includes 270 shares acquired through dividend reinvestment since the last report filed by the reporting person. F3 Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 The performance share units vested on April 24, 2026. References: F1, F2	M Exercise / conversionOrdinary Shares · Non-derivative	15,195A	Direct	Form 4 ↗0001708062-26-000004
2026-05-26Filed 2026-05-28	Martha GeoffreyDirector · Officer · Chairman and CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026. F2 Includes 1,743 shares acquired through dividend reinvestment since the last report filed by the reporting person. F3 Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 The performance share units vested on April 24, 2026. References: F3, F4	M Exercise / conversionPerformance Share Unit · Derivative	85,461D	Direct	Form 4 ↗0001560409-26-000004
2026-05-26Filed 2026-05-28	Martha GeoffreyDirector · Officer · Chairman and CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026. F2 Includes 1,743 shares acquired through dividend reinvestment since the last report filed by the reporting person. F3 Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 The performance share units vested on April 24, 2026. References: F1, F2	M Exercise / conversionOrdinary Shares · Non-derivative	94,963A	Direct	Form 4 ↗0001560409-26-000004
2026-05-26Filed 2026-05-28	Wall Brett A.Officer · EVP & Pres Neuroscience Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026. F2 Includes 527 shares acquired through dividend reinvestment since the last report filed by the reporting person. F3 Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 The performance share units vested on April 24, 2026. References: F3, F4	M Exercise / conversionPerformance Share Unit · Derivative	24,214D	Direct	Form 4 ↗0001473812-26-000002
2026-05-26Filed 2026-05-28	Wall Brett A.Officer · EVP & Pres Neuroscience Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026. F2 Includes 527 shares acquired through dividend reinvestment since the last report filed by the reporting person. F3 Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 The performance share units vested on April 24, 2026. References: F1, F2	M Exercise / conversionOrdinary Shares · Non-derivative	26,907A	Direct	Form 4 ↗0001473812-26-000002

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.